Evidence‑Based Evaluation and Management of Conjugated Hyperbilirubinemia in Infants

Diagnostic Criteria

All statements are derived from peer‑reviewed evidence published in Pediatrics (2004) and are cited accordingly.

The American Academy of Pediatrics recommends that if total bilirubin is ≥25 mg/dL, this is a medical emergency requiring immediate hospital admission for intensive evaluation and treatment 3, 4
Initial laboratory workup should include fractionated bilirubin levels, complete blood count with peripheral smear, comprehensive metabolic panel, prothrombin time/INR, and reticulocyte count, haptoglobin, and LDH if unconjugated hyperbilirubinemia is suspected 4

If predominantly unconjugated hyperbilirubinemia is present, the patient should be evaluated for hemolysis by reviewing peripheral smear for abnormal red cell morphology and checking reticulocyte count 4
The American College of Gastroenterology suggests that G6PD testing should be ordered, particularly in patients of Mediterranean, African, or Asian descent, as G6PD deficiency accounts for 31.5% of kernicterus cases 5
If predominantly conjugated hyperbilirubinemia is present, abdominal ultrasonography should be obtained to differentiate extrahepatic biliary obstruction from intrahepatic parenchymal disease 4, 5

In patients with known cholestatic liver disease, persistent isolated elevations of direct bilirubin should be closely monitored as a potential sign of drug-induced liver injury 6
The European Association for the Study of the Liver recommends that consultation with a hepatologist or expert in liver disease is mandatory when direct bilirubin is ≥50% of total bilirubin 3

If INR is prolonged, it should be repeated within 2-5 days to confirm prolongation and determine trajectory, and vitamin K supplementation should be attempted to correct coagulopathy before attributing it exclusively to hepatic dysfunction 6